Ascendis Pharma A/S 2021 SR
The report outlines Ascendis Pharma's corporate responsibility activities for 2021, focusing on four pillars: Patients, Society, Environment, and Integrity. Key highlights include the US launch of their first commercial product, the establishment of a global Animal Welfare Committee, and the introduction of a Data Ethics Policy. The company also introduced the 'Vision 3x3' strategic roadmap and grew its workforce to 639 employees. Ascendis Pharma aligns its activities with UN Sustainable Development Goals 3, 8, 12, and 16 and plans to initiate a double materiality assessment in 2022.
Company: Ascendis Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2021
Type: SR
Pages: 26
Back to company
Ascendis Pharma A/S
Corporate Responsibility Report
The report outlines Ascendis Pharma's corporate responsibility activities for 2021, focusing on four pillars: Patients, Society, Environment, and Integrity. Key highlights include the US launch of their first commercial product, the establishment of a global Animal Welfare Committee, and the introduction of a Data Ethics Policy. The company also introduced the 'Vision 3x3' strategic roadmap and grew its workforce to 639 employees. Ascendis Pharma aligns its activities with UN Sustainable Development Goals 3, 8, 12, and 16 and plans to initiate a double materiality assessment in 2022.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Mar 1, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees